FluoRok raises $30m in a Series A round to scale up its hydrogen-fluoride-free chemical processes.
The oversubscribed round was led by Orano Venture Fund and Supernova Invest.
≈ £22.3M at $1 = £0.7428 on 5 Nov 2026
FluoRok is an Oxford-based spinout developing chemical manufacturing processes that eliminate the need for toxic hydrogen fluoride.
Oxford spinout FluoRok has secured $30m in Series A funding to build demonstrator facilities and scale its chemical manufacturing technology. The capital will also support further recruitment, customer validation, and commercial partnerships.
The round was led jointly by Orano Venture Fund and Supernova Invest, with participation from Bidra Innovation Ventures, CPI Enterprises, EverQuest Capital Partners, and WS Investment alongside angel investors. Existing backers including Oxford Science Enterprises, BGF, Green Generation Fund, Volta Energy Technologies, and the University of Oxford also contributed.
The financing package additionally includes $1.3m in grant funding from Innovate UK via its Investor Partnerships programme.
From the founder
"Closing another oversubscribed round, backed by both new and existing investors from around the world, is a testament to the strength of our technology, the incredible commercial traction and the speed of execution of the FluoRok team. This funding will ensure FluoRok can swiftly move from start-up to scale-up and take a further step towards becoming a large-scale industrial manufacturer,"
Gabriele Pupo
Chief Executive at FluoRok
Use of funds
- 01Grow the team
- 02Fund research and development
- 03Accelerate go-to-market
Investors
Orano Venture Fund
Supernova Invest
Bidra Innovation Ventures
Oxford Science Enterprises
BGF
Green Generation Fund
Volta Energy Technologies
University of Oxford
CPI Enterprises
EverQuest Capital Partners
WS Investment
Innovate UK